ebomi
Colour theme
Sign in
Insider · CIK 0001388325

Novo Holdings A/S

CIK 0001388325 Name as filed on the most recent filing

Filed as Novo Holdings A/S (66)· Novo A/S (69)

724 transaction lines · from 135 filings · filed 2007-02-02 to 2026-05-05 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised. The 40 most recent are shown; the catalog may hold more for this insider.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-26 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

724 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-26 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2021-02-18 S, Open-market sale Galera Therapeutics, Inc.GRTX 5,290,000, disposed Open Form 4 filing 0001209191-21-012452
2021-02-09 P, Open-market purchase Bolt Biotherapeutics, Inc.BOLT 8,000,000, acquired Open Form 4 filing 0001209191-21-009720
2021-01-28 S, Open-market sale Inozyme Pharma, Inc.INZY 7,875,000, disposed Open Form 4 filing 0001209191-21-006446
2020-11-02 P, Open-market purchase Galecto, Inc.GLTO 4,999,995, acquired Open Form 4 filing 0001209191-20-057030
2020-10-20 P, Open-market purchase Aligos Therapeutics, Inc.ALGS 3,000,000, acquired Open Form 4 filing 0001209191-20-055572
2020-10-20 P, Open-market purchase Eargo, Inc.EAR 2,700,000, acquired Open Form 4 filing 0001209191-20-055573
2020-10-15 S, Open-market sale Galera Therapeutics, Inc.GRTX 4,950,000, disposed Open Form 4 filing 0001209191-20-055281
2020-10-14 P, Open-market purchase Spruce Biosciences, Inc.SPRB 3,750,000, acquired Open Form 4 filing 0001209191-20-055062
2020-08-21 P, Open-market purchase Harmony Biosciences Holdings, Inc.HRMY 3,180,072, acquired Open Form 4 filing 0001209191-20-048226
2020-08-11 P, Open-market purchase Checkmate Pharmaceuticals, Inc.CMPI 7,500,000, acquired Open Form 4 filing 0001209191-20-046622
2020-07-28 P, Open-market purchase Inozyme Pharma, Inc.INZY 6,000,000, acquired Open Form 4 filing 0001209191-20-043953
2020-07-14 P, Open-market purchase Nkarta, Inc.NKTX 9,999,990, acquired Open Form 4 filing 0001209191-20-042633
2020-07-08 S, Open-market sale Corvus Pharmaceuticals, Inc.CRVS 3,985,166, disposed Open Form 4 filing 0001209191-20-041990
2020-07-07 S, Open-market sale Corvus Pharmaceuticals, Inc.CRVS 4,183,381, disposed Open Form 4 filing 0001209191-20-041990
2019-11-25 S, Open-market sale Milestone Pharmaceuticals Inc.MIST 3,840,000, disposed Open Form 4 filing 0001209191-19-058290
2019-11-12 P, Open-market purchase Galera Therapeutics, Inc.GRTX 6,000,000, acquired Open Form 4 filing 0001209191-19-056527
2019-07-25 S, Open-market sale Corvus Pharmaceuticals, Inc.CRVS 5,600,000, disposed Open Form 4 filing 0001209191-19-043285
2019-07-24 S, Open-market sale Corvus Pharmaceuticals, Inc.CRVS 266,711, disposed Open Form 4 filing 0001209191-19-043285
2019-07-23 S, Open-market sale Corvus Pharmaceuticals, Inc.CRVS 211,134, disposed Open Form 4 filing 0001209191-19-043285
2019-07-22 P, Open-market purchase Mirum Pharmaceuticals, Inc.MIRM 8,625,000, acquired Open Form 4 filing 0001209191-19-042970
2019-06-28 P, Open-market purchase Morphic Holding, Inc.MORF 10,000,005, acquired Open Form 4 filing 0001209191-19-039726
2019-05-13 P, Open-market purchase Milestone Pharmaceuticals Inc.MIST 4,999,995, acquired Open Form 4 filing 0001209191-19-029660
2018-09-28 P, Open-market purchase Entasis Therapeutics Holdings Inc.ETTX 16,347,525, acquired Open Form 4 filing 0001209191-18-052791
2018-03-12 P, Open-market purchase Corvus Pharmaceuticals, Inc.CRVS 9,999,995, acquired Open Form 4 filing 0001209191-18-019270
2017-10-12 S, Open-market sale KalVista Pharmaceuticals, Inc.KALV 2 lines 14,675,820, disposed Open Form 4 filing 0001209191-17-056766
2017-10-11 S, Open-market sale KalVista Pharmaceuticals, Inc.KALV 362,763, disposed Open Form 4 filing 0001209191-17-056766
2017-10-10 S, Open-market sale KalVista Pharmaceuticals, Inc.KALV 6 lines 11,232,600, disposed Open Form 4 filing 0001209191-17-056766
2017-09-15 S, Open-market sale KalVista Pharmaceuticals, Inc.KALV 985,841, disposed Open Form 4 filing 0001209191-17-053224
2017-09-15 S, Open-market sale KalVista Pharmaceuticals, Inc.KALV 2 lines 985,865, disposed Open Form 4 filing 0001209191-17-053073
2017-09-14 S, Open-market sale KalVista Pharmaceuticals, Inc.KALV 80,500, disposed Open Form 4 filing 0001209191-17-053224
2017-09-14 S, Open-market sale KalVista Pharmaceuticals, Inc.KALV 80,500, disposed Open Form 4 filing 0001209191-17-053073
2017-09-13 S, Open-market sale KalVista Pharmaceuticals, Inc.KALV 207,614, disposed Open Form 4 filing 0001209191-17-053224
2017-09-13 S, Open-market sale KalVista Pharmaceuticals, Inc.KALV 207,614, disposed Open Form 4 filing 0001209191-17-053073
2017-08-25 S, Open-market sale HTG Molecular Diagnostics, IncHTGM 1,260,591, disposed Open Form 4 filing 0001209191-17-050346
2017-08-24 S, Open-market sale HTG Molecular Diagnostics, IncHTGM 729,919, disposed Open Form 4 filing 0001209191-17-050346
2017-08-23 S, Open-market sale HTG Molecular Diagnostics, IncHTGM 95,475, disposed Open Form 4 filing 0001209191-17-050346
2017-08-22 S, Open-market sale HTG Molecular Diagnostics, IncHTGM 25,412, disposed Open Form 4 filing 0001209191-17-049870
2017-08-21 S, Open-market sale Anaptysbio IncANAB 7,518,251, disposed Open Form 4 filing 0001209191-17-049733
2017-08-21 S, Open-market sale HTG Molecular Diagnostics, IncHTGM 25,976, disposed Open Form 4 filing 0001209191-17-049870
2017-08-18 S, Open-market sale HTG Molecular Diagnostics, IncHTGM 115,600, disposed Open Form 4 filing 0001209191-17-049870
2017-08-15 S, Open-market sale Anaptysbio IncANAB 3,011,988, disposed Open Form 4 filing 0001209191-17-049237
2017-08-14 S, Open-market sale Anaptysbio IncANAB 766,493, disposed Open Form 4 filing 0001209191-17-049237
2017-08-07 S, Open-market sale Anaptysbio IncANAB 10,128,000, disposed Open Form 4 filing 0001209191-17-048152

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
%, Ten percent owner
Ten percent owner

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 609
  • Open-market sale 115
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Novo Holdings A/S, insider transactions. Retrieved 2026-08-27 from https://ebomi.com/insider/0001388325

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.